ArticleAllergy2018

Lolium perenne peptide immunotherapy is well tolerated and elicits a protective B-cell response in seasonal allergic rhinitis patients.

R Mösges et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.